Best Growth Investing Strategies for Australian Investors in the Current Market

Last reviewed: May 2026

You've found your growth stocks. Now what? How do you actually build a strategy around them that doesn't implode when the market gets choppy?

We think there are three proven approaches that work for Australian investors in 2026, and they're not mutually exclusive. Mix them together and you've got something resilient.

What is GARP investing and how does it work on the ASX?

GARP is probably the best framework for growth investing on the ASX. It sits between pure growth (buying anything that grows fast) and pure value (waiting for prices to crash before acting).

The idea is simple: buy quality growth companies, but only when they're not absurdly expensive.

How do you define "reasonable"? We use the PEG ratio. Take the P/E multiple and divide it by the expected earnings growth rate. A company trading at 35x earnings that's growing earnings at 25% annually has a PEG of 1.4. That's reasonable for a compounder with a genuine moat. Compare that to a stock at 15x earnings growing at 5%, PEG of 3. That's expensive for mediocre growth.

GARP works because it forces discipline. You're not chasing moonshots or waiting for a 70% crash before buying. You're buying quality at a fair price, and that's a repeatable process. On the ASX in 2026, this might mean owning quality growth compounders like WiseTech Global and selected healthcare names, but only when the PEG signals value, not when the story's already fully priced.

How does buy-and-hold compounding work for growth investors?

Here's a fact that upsets people: most investors dramatically underestimate the power of holding good stocks for 20-plus years.

A company compounding earnings at 15% annually becomes a very different animal after a decade. Earnings are 4x larger. That means the stock price, if valued at a consistent multiple, is also 4x larger. Add reinvested dividends (or franking credits ploughed back in), and you're looking at extraordinary wealth creation from a small number of positions.

This strategy works if, and only if, you pick real compounders. Companies with durable competitive advantages, predictable earnings, and reinvestment opportunities that compound at high rates of return.

Frankly, this is harder on the ASX than on Wall Street. We don't have as many 30-year compounders. But we've got some. CSL was one for a long time. WiseTech Global could be one. Selected healthcare services businesses with demographic tailwinds might compound quietly for decades. You have to find them early and hold through the volatility, which is the hard part.

The discipline required is brutal. You'll watch your stock do nothing for two years and wonder if you made a mistake. Then it'll double in eighteen months. Then the whole cycle repeats. If you can't handle that, or if you need the money inside five years, buy-and-hold isn't for you.

What are the best thematic growth investing themes on the ASX in 2026?

Instead of picking individual stocks, you build a portfolio around structural tailwinds that will drive growth for a decade or more regardless of which individual company wins.

On the ASX right now, we're watching three themes carefully:

Healthcare and Aged Care

Australia's population is ageing. Healthcare spending is a straight line up. This creates opportunities in pathology, imaging, aged care operations, medical devices, and the technology that serves them. A diversified portfolio of stocks riding this wave could do well for 20 years regardless of individual execution risk, because the demand driver is demographic, not cyclical.

Decarbonisation and Clean Energy Enablers

The ASX doesn't have many pure-play renewables worth owning. Most are still loss-making. But it does have companies enabling the transition: lithium and critical minerals miners, battery technology, infrastructure providers for renewable energy, and electrification plays. This theme will outlive government subsidies because the economics now genuinely favour renewables in most applications.

Digital Transformation and Tech-Adjacent Plays

Cloud adoption, cybersecurity, digital payments, data analytics. On the ASX these are still early-stage themes relative to global markets. WiseTech (logistics software), selected healthcare-tech names, and companies automating traditional industries are all riding digital transformation. The addressable market is enormous and local penetration is still relatively low.

The advantage of thematic investing is diversification within conviction. Instead of betting on one company, you're betting on a macro trend. If one stock disappoints, others in the theme still benefit. The disadvantage: you need real conviction that the theme will play out, and you need to identify which companies are genuinely positioned to win, not just those that use the right buzzwords.

How should I size my positions in ASX growth stocks?

This is where most investors go wrong. They find a compelling growth stock and throw 30% of their portfolio at it. Then it falls 50%, and they're furious, or worse, they panic-sell at the bottom.

Here's our framework: size positions by conviction and volatility, not by excitement.

A core growth holding, high conviction, reasonable valuation, strong fundamentals, deserves 5 to 8% of your portfolio. Three of these gives you 15 to 24% in quality growth. That's enough to materially improve returns without blowing up your wealth.

A satellite position, higher risk, earlier stage, smaller-cap, deserves 2 to 3%. These are the "if it works out, great; if it doesn't, the portfolio survives" plays.

Everything else stays in value and defensive positions. This lets you compound at 8 to 10% annually over a cycle, with drawdowns you can actually tolerate.

When should I sell a growth stock?

Knowing when to buy a growth stock is hard. Knowing when to sell is harder.

You don't sell because the stock is up 100%. You don't sell because the market is down 20%. You sell when:

Fundamentals deteriorate. Growth slows materially below your original thesis, margins compress consistently, management changes, or the competitive position erodes. If the reason you bought the stock changes, the rationale for holding it should change too.

Valuation becomes extreme. If your compounder is now trading at 70x earnings with 20% growth, it's priced to perfection. A single earnings miss will crater it. Take profits and redeploy.

The thesis is complete. The company was a high-growth disruptor. Now it's the established player growing at 8% annually. Sell and move on to the next growth engine.

Better opportunities emerge. You have good conviction in Stock A, but Stock B now offers better growth at better value. Swapping is capital reallocation, not trading for the sake of it, but disciplined portfolio management.

The worst reason to sell: you're down 20% and panicking. Growth stocks are volatile. That's the price of admission. If nothing has changed with the fundamentals, a short-term drawdown is noise, not signal.

What is the ASX growth opportunity in 2026?

The Australian market is shifting. For much of the past decade, the best returns came from banks and miners, low growth, high yield. But that cycle is maturing.

The next decade's returns look different. Healthcare, technology-adjacent businesses, and clean energy enablers are where the growth is concentrating. The RBA rate cycle has turned, rates are stabilising or falling, which removes the headwind that crushed growth stocks from 2022 to 2024. Earnings growth will matter more than yield again. For patient growth investors who've been biding their time, this creates real opportunity.

Your action plan

Decide which strategy fits your temperament. GARP is the goldilocks approach, disciplined enough to avoid traps, aggressive enough to drive real returns. Buy-and-hold suits the patient investor who picks well and ignores noise. Thematic investing suits those who trust structural trends over individual stock selection.

Size your positions properly. 20 to 30% of your total portfolio in quality growth, the rest in value and defensives. This keeps you compounding without the risk of a major blowup.

If you want help identifying which ASX stocks meet your growth criteria, or you'd like to stress-test your current portfolio, our Mosaic platform and regular webinars are built for exactly this.

Frequently Asked Questions